2026-09-17 09:00
Biovica, a company specializing in blood-based cancer monitoring, today announced the publication of a new systematic review and meta-analysis in the peer-reviewed journal The Breast. The study brings together the available clinical evidence for circulating...
2026-09-16 18:05
The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 16 September 2026 and the following resolutions were passed by the meeting.
2026-09-09 17:50
Biovica delivered 56% sales growth in the first quarter, driven by strong Pharma Services momentum, while taking decisive actions to streamline operations, strengthen leadership, and position the company for its next phase of growth.
2026-09-09 17:46
The shareholders of Biovica International AB, reg. no. 556774-6150 (the "Company"), are hereby invited to the extra general meeting to be held on Wednesday 30 September 2026, at 14:30 CEST at Baker McKenzie Advokatbyrå's office at Mäster Samuelsgatan...
2026-09-09 17:45
INSIDE INFORMATION: The board of directors of Biovica International AB (publ) ("Biovica" or the "Company") has today resolved, subject to subsequent approval by an extraordinary general meeting, to carry out a new share issue of B-shares of approximately...
2026-08-27 12:00
Biovica, a company specializing in blood-based cancer monitoring, today announces that it has entered into a Master Services Agreement (MSA) with an operating subsidiary of a U.S.-based biotechnology company developing next-generation precision medicines...
2026-08-25 09:00
Biovica, a company specializing in blood-based cancer monitoring, today announced that new results involving DiviTum® TKa have been published in the peer-reviewed journal Clinical Cancer Research.
2026-08-19 09:00
Biovica, a company specializing in blood-based cancer monitoring and oncology drug development services, today announced that it has received a new Pharma Services work order from an existing TIER-2 pharmaceutical customer.
2026-08-14 08:00
The shareholders of Biovica International AB, reg. no. 556774-6150 (the "Company"), are hereby invited to the annual general meeting to be held on Wednesday 16 September 2026, at 15.00 CEST at Conference Hubben, Dag Hammarskjölds Väg 38 in Uppsala...
2026-08-06 09:00
Biovica, a company specializing in blood-based cancer monitoring, today announced that it has entered into a laboratory services agreement with one of the leading cancer centers in the United States, designated by the National Cancer Institute as a Comprehensive...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects